The infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
associated not only with the development of acute disease but also with long-term symptoms …

Although coronavirus disease 2019 (COVID-19) is regarded as an acute, resolving infection
followed by the development of protective immunity, recent systematic literature review …

The COVID-19 global pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection has infected hundreds of millions of individuals …

The host immunity is crucial in determining the clinical course and prognosis of coronavirus
disease 2019, where some systemic and severe manifestations are associated with …

During the pandemic of COVID-19, numerous waves of infections affected the two
hemispheres with different impacts on each country. Throughout these waves, and with the …

Considerable research has been done in investigating SARS‐CoV‐2 infection, its
characteristics, and host immune response. However, debate is still ongoing over the …

Highlights•Post-acute sequelae of SARS-CoV-2 (PASC) are associated with persistent
inflammation.•The antigens or other immune stimuli driving PASC are still unclear.•PASC …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been redetected after
discharge in some coronavirus disease 2019 (COVID-19) patients. The reason for the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent for the
2019 coronavirus disease (COVID-19) pandemic, has caused a public health emergency …

Emerging human coronaviruses, including the recently identified SARS-CoV-2, are relevant
respiratory pathogens due to their potential to cause epidemics with high case fatality rates …